Abbott Laboratories (NYSE: $ABT) announced Q1 fiscal 2025 results on Wednesday, April 16th. The healthcare firm posted $1.33 billion in net income. Adjusted earnings reached […]
Tag: NYSE: ABT
Abbott Laboratories (NYSE: $ABT) Reports Q4 Results, Stock Slides
Abbott Laboratories (NYSE: $ABT) is a manufacturer of medical devices, diagnostics products, nutritional products, and branded generic pharmaceutical products. On January 24, 2024, the company […]